Esraa A. Kandil

Esraa A. Kandil

Auto-generated profile, based on publicly available information

Esraa A. Kandil

Department of Pharmacology and Toxicology, Faculty of Pharmacy, Cairo University, Cairo, Egypt

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2016 in Neuroscience
Verified
Journal Article
Closed access
EKEsraa A. Kandil
Esraa A. Kandil
NANoha Abdelkader
Noha Abdelkader
BEBahia M. El-Sayeh
Bahia M. El-Sayeh
SSSamira Saleh
Samira Saleh

9 June 2022 in Progress in Neuro-Psychopharmacology and Biological Psychiatry
Verified
Journal Article
Closed access
WIWeam W. Ibrahim
Weam W. Ibrahim
RSRabab Sayed
Rabab Sayed
EKEsraa A. Kandil
Esraa A. Kandil
WWWalaa Wadie
Walaa Wadie

1 January 2021 in Oxidative Medicine and Cellular Longevity
Verified
Journal Article
Open access
PDF file
NEnesrine elsayed
nesrine elsayed
EKEsraa A. Kandil
Esraa A. Kandil
MGMamdooh Ghoneum
Mamdooh Ghoneum
Alzheimer’s disease (AD) is a neurodegenerative disease characterized by cognitive impairment. Gut microbiota dysfunction (dysbiosis) is implicated in the pathology of AD and is associated with several detrimental consequences, including neurotransmitter depletion, oxidative stress, inflammation, apoptosis, and insulin resistance, which all contribute to the onset of AD. The objective of this study was to assess the effectiveness of Probiotics Fermentation Technology (PFT), a kefir product, in alleviating AD symptoms via regulation of the gut microbiota using a streptozotocin‐ (STZ‐) induced AD mouse model and to compare its activity with simvastatin, which has been proven to effectively treat AD. Mice received one intracerebroventricular injection of STZ (3 mg/kg). PFT (100, 300, 600 mg/kg) and simvastatin (20 mg/kg) were administered orally for 3 weeks. PFT supplementation mitigated STZ‐induced neuronal degeneration in the cortex and hippocampus, restored hippocampal acetylcholine levels, and improved cognition in a dose‐dependent manner. These effects were accompanied by reductions in oxidative damage, proinflammatory cytokine expression, apoptosis, and tau hyperphosphorylation. Moreover, PFT hindered amyloid plaque accumulation via the enhancement of insulin‐degrading enzyme. These beneficial effects were comparable to those produced by simvastatin. The results suggest that PFT can alleviate AD symptoms by regulating the gut microbiota and by inhibiting AD‐related pathological events.

25 October 2022 in Life Sciences
Verified
Journal Article
Closed access
ASAya S. Sayed
Aya S. Sayed
NSNesrine S. El Sayed
Nesrine S. El Sayed
BBBarbara Budzyńska
Barbara Budzyńska
KSKrystyna Skalicka-Woźniak
Krystyna Skalicka-Woźniak
MAMariam K. Ahmed
Mariam K. Ahmed
EKEsraa A. Kandil
Esraa A. Kandil

13 August 2019 in Clinical and Experimental Pharmacology and Physiology
Verified
Journal Article
Closed access
PDF file
EKEsraa A. Kandil
Esraa A. Kandil
RSRabab Sayed
Rabab Sayed
LALamia A. Ahmed
Lamia A. Ahmed
MFMai A. Abd El Fattah
Mai A. Abd El Fattah
BEBahia M. El‐Sayeh
Bahia M. El‐Sayeh